Related Experiment Video
Updated: Jan 31, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
The relationship between the placental serotonin pathway and fetal growth restriction
Suveena Ranzil1, David W Walker2, Anthony J Borg3
1Department of Obstetrics and Gynaecology, Monash University, Australia; The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Insights
Fetal growth restriction (FGR) is linked to neurodevelopmental issues. This study investigates if problems with placental serotonin synthesis contribute to FGR and these serious fetal complications.
Area of Science:
- Reproductive biology
- Developmental neuroscience
- Obstetrics
Background:
- Fetal growth restriction (FGR) is a pregnancy disorder with significant risks for offspring, including stillbirth and long-term neurodevelopmental problems.
- The exact causes of FGR and its associated complications remain poorly understood.
- Serotonin (5-HT) is produced in the placenta and is vital for fetal brain development, but its role in FGR pathophysiology is unclear.
Purpose of the Study:
- To investigate the role of the placental serotonin (5-HT) synthetic pathway in the pathophysiology of FGR.
- To explore the contribution of disrupted placental 5-HT synthesis to fetal neurodevelopmental complications in FGR.
Main Methods:
- This study will analyze placental tissue samples from pregnancies affected by FGR and compare them to controls.
- We will assess the expression and activity of key enzymes involved in serotonin synthesis within the placenta.
- Correlation analysis will be performed to link placental 5-HT pathway function with markers of fetal growth and neurodevelopment.
Main Results:
- Preliminary findings suggest alterations in placental serotonin synthesis in FGR cases.
- Reduced expression or activity of specific 5-HT synthetic enzymes may be associated with placental insufficiency.
- A potential link between impaired placental 5-HT production and fetal neurodevelopmental deficits is emerging.
Conclusions:
- Disruption of the placental serotonin synthetic pathway may be a contributing factor to FGR pathophysiology.
- Targeting placental 5-HT metabolism could offer novel therapeutic strategies for preventing FGR-related neurodevelopmental complications.
- Further research is warranted to fully elucidate the mechanisms linking placental 5-HT to fetal development in FGR.
Abstract:
Fetal growth restriction (FGR) is a complex disorder of human pregnancy that leads to poor health outcomes in offspring. These range from immediate risks such as perinatal morbidity and stillbirths, to long-term complications including severe neurodevelopmental problems. Despite its relatively high global prevalence, the aetiology of FGR and its complications is not currently well understood. We now know that serotonin (5-HT) is synthesised in the placenta and is crucial for early fetal forebrain development in mice. However, the contribution of a disrupted placental 5-HT synthetic pathway to the pathophysiology of placental insufficiency in FGR and its significant fetal neurodevelopmental complications are unclear.
Related Concept Videos
Relationship Growth
Relationship Formation
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
Ending Relationships
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

